BRPI0412447A - método para a preparação de mirtazapina enantiomericamente pura, e, método para a seleção de um ácido ou uma combinação ácido/solvente apropriada para uma reação de fechamento de anel estereoespecìfica de composto enantiomericamente puro - Google Patents
método para a preparação de mirtazapina enantiomericamente pura, e, método para a seleção de um ácido ou uma combinação ácido/solvente apropriada para uma reação de fechamento de anel estereoespecìfica de composto enantiomericamente puroInfo
- Publication number
- BRPI0412447A BRPI0412447A BRPI0412447-2A BRPI0412447A BRPI0412447A BR PI0412447 A BRPI0412447 A BR PI0412447A BR PI0412447 A BRPI0412447 A BR PI0412447A BR PI0412447 A BRPI0412447 A BR PI0412447A
- Authority
- BR
- Brazil
- Prior art keywords
- enantiomerically pure
- acid
- solvent
- ring
- mirtazapine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
"MéTODO PARA A PREPARAçãO DE MIRTAZAPINA ENANTIOMERICAMENTE PURA, E, MéTODO PARA A SELEçãO DE UM ACIDO OU UMA COMBINAçãO áCIDO/SOLVENTE APROPRIADA PARA UMA REAçãO DE FECHAMENTO DE ANEL ESTEREOESPECìFICA DE COMPOSTO ENANTIOMERICAMENTE PURO". A invenção provê um método para a preparação de mirtazapina enantiomericamente pura, compreendendo uma etapa de fechamento de anel de um composto de fórmula (II) em que X é um grupo de saída, cuja a etapa compreende o tratamento com um ácido, pelo que mirtazapina com excesso enantiomérico é formada pelo fechamento de anel do composto de fórmula (II) com excesso enantiomérico por tratamento com um ácido apropriado na ausência de um solvente ou uma combinação apropriada de um ácido e um solvente orgânico.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03102095 | 2003-07-10 | ||
| PCT/EP2004/051357 WO2005005410A1 (en) | 2003-07-10 | 2004-07-05 | A method for the preparation of enantiomerically pure mirtazapine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0412447A true BRPI0412447A (pt) | 2006-09-19 |
Family
ID=34042934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0412447-2A BRPI0412447A (pt) | 2003-07-10 | 2004-07-05 | método para a preparação de mirtazapina enantiomericamente pura, e, método para a seleção de um ácido ou uma combinação ácido/solvente apropriada para uma reação de fechamento de anel estereoespecìfica de composto enantiomericamente puro |
Country Status (36)
| Country | Link |
|---|---|
| US (2) | US8058436B2 (pt) |
| EP (1) | EP1656365B1 (pt) |
| JP (1) | JP4668184B2 (pt) |
| KR (1) | KR20060056315A (pt) |
| CN (1) | CN100558722C (pt) |
| AR (1) | AR046494A1 (pt) |
| AT (1) | ATE433965T1 (pt) |
| AU (1) | AU2004255874B2 (pt) |
| BR (1) | BRPI0412447A (pt) |
| CA (1) | CA2531165C (pt) |
| CO (1) | CO5640123A2 (pt) |
| CY (1) | CY1109327T1 (pt) |
| DE (1) | DE602004021605D1 (pt) |
| DK (1) | DK1656365T3 (pt) |
| EC (1) | ECSP066271A (pt) |
| ES (1) | ES2327123T3 (pt) |
| HK (1) | HK1086841A1 (pt) |
| HR (1) | HRP20051019A2 (pt) |
| IL (1) | IL172549A0 (pt) |
| IS (1) | IS2674B (pt) |
| LT (1) | LT5382B (pt) |
| LV (1) | LV13441B (pt) |
| MX (1) | MXPA06000325A (pt) |
| NO (1) | NO20056175L (pt) |
| NZ (1) | NZ544360A (pt) |
| PE (1) | PE20050323A1 (pt) |
| PL (1) | PL1656365T3 (pt) |
| PT (1) | PT1656365E (pt) |
| RS (1) | RS20050972A (pt) |
| RU (1) | RU2352566C2 (pt) |
| SG (1) | SG144914A1 (pt) |
| SI (1) | SI1656365T1 (pt) |
| TW (1) | TWI335915B (pt) |
| UA (1) | UA83666C2 (pt) |
| WO (1) | WO2005005410A1 (pt) |
| ZA (1) | ZA200600019B (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5080050B2 (ja) * | 2005-09-26 | 2012-11-21 | 住友化学株式会社 | 光学活性なピペラジン化合物の製造方法 |
| WO2007035003A1 (ja) * | 2005-09-26 | 2007-03-29 | Sumitomo Chemical Company, Limited | 光学活性なピペラジン化合物の製造方法 |
| TW200808804A (en) * | 2006-05-22 | 2008-02-16 | Organon Nv | Mirtazapine for the treatment of neuropathic pain |
| TW200815370A (en) * | 2006-06-16 | 2008-04-01 | Organon Nv | Stereoselective synthesis of (S)-1-methyl-3-phenylpiperazine |
| US8273883B2 (en) | 2007-02-09 | 2012-09-25 | Kaneka Corporation | Method for producing optically active 2-arylpiperazine derivative |
| JP5192707B2 (ja) * | 2007-03-22 | 2013-05-08 | 住友化学株式会社 | ミルタザピンの製造方法 |
| CA2684021A1 (en) * | 2007-04-11 | 2008-10-23 | N.V. Organon | A method for the preparation of an enantiomer of a tetracyclic benzazepine |
| US7994314B2 (en) | 2007-04-11 | 2011-08-09 | N.V. Organon | Method for the preparation of an enantiomerically pure benzazepine |
| KR101485418B1 (ko) * | 2013-05-29 | 2015-01-26 | 주식회사 메디켐코리아 | 고순도 미르타자핀의 제조방법 |
| HUE055000T2 (hu) | 2015-02-27 | 2021-10-28 | Dechra Ltd | Étvágy stimulálása, tömegvesztés kézbentartása és anorexia kezelése kutyák és macskák esetében |
| KR102540021B1 (ko) * | 2020-12-02 | 2023-06-07 | (주)유케이케미팜 | 대량 생산에 적합한 미르타자핀의 제조방법 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3959470A (en) * | 1972-11-28 | 1976-05-25 | Mikhail Davidovich Mashkovsky | Psychotropic medicinal preparation |
| NL189199C (nl) * | 1975-04-05 | 1993-02-01 | Akzo Nv | Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. |
| IE903557A1 (en) * | 1989-10-05 | 1991-04-10 | Sankyo Co | Novel tetracyclic compounds having anti-allergic and¹anti-asthmatic activities, their preparation and use |
| JPH11222407A (ja) * | 1997-11-14 | 1999-08-17 | Sankyo Co Ltd | 新規殺菌剤 |
| PL192272B1 (pl) | 1997-11-14 | 2006-09-29 | Akzo Nobel Nv | Zastosowanie mirtazapiny |
| US20030069417A1 (en) * | 1999-04-19 | 2003-04-10 | Claude Singer | Novel synthesis and crystallization of piperazine ring-containing compounds |
| WO2000062782A1 (en) | 1999-04-19 | 2000-10-26 | Teva Pharmaceutical Industries Ltd. | Novel synthesis and crystallization of piperazine ring-containing compounds |
| US6068695A (en) * | 1999-07-13 | 2000-05-30 | Bayer Corporation | Process for the continuous preparation of quinacridones |
| AU6476300A (en) | 1999-09-30 | 2001-05-10 | Sumika Fine Chemicals Co., Ltd. | Process for the preparation of a piperazine derivative |
| WO2001042239A1 (fr) | 1999-12-13 | 2001-06-14 | Sumika Fine Chemicals Co., Ltd. | Procede de preparation d'un compose pyridinemethanol |
| ATE317261T1 (de) | 2000-02-11 | 2006-02-15 | Akzo Nobel Nv | Verwendung von mirtazapin zur behandlung von schlafstörungen |
| JP2001342188A (ja) * | 2000-03-27 | 2001-12-11 | Takeda Chem Ind Ltd | 縮合ピラゾール誘導体、その製造法および用途 |
| TW200538100A (en) * | 2004-04-21 | 2005-12-01 | Akzo Nobel Nv | Mirtazapine salts |
-
2004
- 2004-05-07 UA UAA200600274A patent/UA83666C2/ru unknown
- 2004-06-28 TW TW093118845A patent/TWI335915B/zh not_active IP Right Cessation
- 2004-07-05 US US10/564,193 patent/US8058436B2/en not_active Expired - Fee Related
- 2004-07-05 NZ NZ544360A patent/NZ544360A/en not_active IP Right Cessation
- 2004-07-05 BR BRPI0412447-2A patent/BRPI0412447A/pt not_active IP Right Cessation
- 2004-07-05 PT PT04741958T patent/PT1656365E/pt unknown
- 2004-07-05 ES ES04741958T patent/ES2327123T3/es not_active Expired - Lifetime
- 2004-07-05 JP JP2006518216A patent/JP4668184B2/ja not_active Expired - Lifetime
- 2004-07-05 KR KR1020067000511A patent/KR20060056315A/ko active IP Right Grant
- 2004-07-05 MX MXPA06000325A patent/MXPA06000325A/es active IP Right Grant
- 2004-07-05 AU AU2004255874A patent/AU2004255874B2/en not_active Expired
- 2004-07-05 CA CA2531165A patent/CA2531165C/en not_active Expired - Fee Related
- 2004-07-05 AT AT04741958T patent/ATE433965T1/de active
- 2004-07-05 EP EP04741958A patent/EP1656365B1/en not_active Expired - Lifetime
- 2004-07-05 RS YUP-2005/0972A patent/RS20050972A/sr unknown
- 2004-07-05 CN CNB2004800194891A patent/CN100558722C/zh not_active Expired - Lifetime
- 2004-07-05 WO PCT/EP2004/051357 patent/WO2005005410A1/en active IP Right Grant
- 2004-07-05 SG SG200805127-8A patent/SG144914A1/en unknown
- 2004-07-05 PL PL04741958T patent/PL1656365T3/pl unknown
- 2004-07-05 RU RU2006103992/04A patent/RU2352566C2/ru not_active IP Right Cessation
- 2004-07-05 SI SI200431183T patent/SI1656365T1/sl unknown
- 2004-07-05 DE DE602004021605T patent/DE602004021605D1/de not_active Expired - Lifetime
- 2004-07-05 DK DK04741958T patent/DK1656365T3/da active
- 2004-07-07 PE PE2004000653A patent/PE20050323A1/es not_active Application Discontinuation
- 2004-07-08 AR ARP040102412A patent/AR046494A1/es not_active Application Discontinuation
-
2005
- 2005-12-12 LT LT2005107A patent/LT5382B/lt not_active IP Right Cessation
- 2005-12-13 IL IL172549A patent/IL172549A0/en not_active IP Right Cessation
- 2005-12-15 IS IS8184A patent/IS2674B/is unknown
- 2005-12-22 HR HR20051019A patent/HRP20051019A2/xx not_active Application Discontinuation
- 2005-12-23 NO NO20056175A patent/NO20056175L/no not_active Application Discontinuation
-
2006
- 2006-01-03 ZA ZA200600019A patent/ZA200600019B/en unknown
- 2006-01-09 EC EC2006006271A patent/ECSP066271A/es unknown
- 2006-01-10 CO CO06001617A patent/CO5640123A2/es not_active Application Discontinuation
- 2006-02-10 LV LVP-06-21A patent/LV13441B/en unknown
- 2006-08-17 HK HK06109133.3A patent/HK1086841A1/xx not_active IP Right Cessation
-
2008
- 2008-07-02 US US12/667,969 patent/US20100179319A1/en not_active Abandoned
-
2009
- 2009-08-25 CY CY20091100894T patent/CY1109327T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CU23337B7 (es) | Resolución de sal quiral | |
| BR0214845A (pt) | Sìntese de 4,5-diidro-pirazol[3,4-c]pirid-2-onas | |
| CY1108866T1 (el) | Βελτιωμενη μεθοδος για την παρασκευη ενωσεων 3-υδροξυ-4-υδροξυμεθυλ-πυρρολιδινης | |
| BRPI0519496A2 (pt) | processo para preparar um composto ou uma composiÇço, e, composiÇço | |
| BRPI0412447A (pt) | método para a preparação de mirtazapina enantiomericamente pura, e, método para a seleção de um ácido ou uma combinação ácido/solvente apropriada para uma reação de fechamento de anel estereoespecìfica de composto enantiomericamente puro | |
| DE60209537D1 (de) | Neue kristalline formen von meloxicam, deren herstellung und verfahren zu deren umwandlung ineinander | |
| ATE442363T1 (de) | Verfahren zur herstellung von pyridinverbindungen | |
| DE602004025267D1 (de) | Verfahren zur herstellung form i von (s)-(+)- clopidogrelbisulfat | |
| DE69915110D1 (de) | Verfahren zur herstellung von arylethern | |
| BR0210019A (pt) | Processo para a preparação de um composto | |
| NO20071817L (no) | Fremgangsmate for a fremstille enantiomeriske imidazolforbindelser | |
| PT1238977E (pt) | Processo para a preparacao de um composto piridinometanolico | |
| HK1099759A1 (en) | A process for the resolution of nefopam | |
| DE69500230D1 (de) | Verfahren zur Herstellung titanhaltiger Zeolithe | |
| ATE423096T1 (de) | Verfahren zur herstellung von 2- azabicycloä3.3.0üoctan-3-carbonsäurederivaten | |
| DE602004014264D1 (de) | Verfahren zur herstellung von olanzapin | |
| DE60105314D1 (de) | Verfahren zur herstellung von taxanderivaten | |
| DE50209620D1 (de) | Verfahren zur Herstellung von kristallinem Cholinascorbat | |
| BR0214445B1 (pt) | processos para a produção de compostos. | |
| DE60003807D1 (de) | Enantiomere von mercaptolactonen und verfahren zu ihrer herstellung | |
| BR0307300A (pt) | Integração de pelo menos dois processos para reutilizar ácido | |
| ATE496038T1 (de) | Verfahren zur herstellung von quetiapin | |
| BR0200042A (pt) | Processo para operar um veìculo automotor bem como conjunto para a concretizacão do processo | |
| BRPI0408771A (pt) | processo para a produção de imidazopiridin-8-onas | |
| PT1444244E (pt) | Processo para a preparacao de desclaritromicina, assim como produtos intermedios |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: PARA: INT. CL. C07D 401/04, 471/14; A61P 25/24 Ipc: C07D 401/04 (2011.01), C07D 471/14 (2011.01), A61P |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2259 DE 22/04/2014. |